Global Ciclopirox Olamine Market Growth (Status and Outlook) 2025-2031

According to this study, the global Ciclopirox Olamine market size will reach US$ million by 2031.

Ciclopirox olamine (used in preparations called Batrafen, Loprox, Mycoster, Penlac and Stieprox) is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses. In particular, the agent is especially effective in treating Tinea versicolor.

United States market for Ciclopirox Olamine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Ciclopirox Olamine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Ciclopirox Olamine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Ciclopirox Olamine players cover Bayer, Apotex Corporation, Fougera (Sandoz), Medimetriks Pharmaceuticals, Taro Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Ciclopirox Olamine Industry Forecast” looks at past sales and reviews total world Ciclopirox Olamine sales in 2024, providing a comprehensive analysis by region and market sector of projected Ciclopirox Olamine sales for 2025 through 2031. With Ciclopirox Olamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ciclopirox Olamine industry.

This Insight Report provides a comprehensive analysis of the global Ciclopirox Olamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Ciclopirox Olamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ciclopirox Olamine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ciclopirox Olamine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ciclopirox Olamine.

This report presents a comprehensive overview, market shares, and growth opportunities of Ciclopirox Olamine market by product type, application, key players and key regions and countries.

Segmentation by Type:
Cream Preparation
Temperture
Vaginal Suppository

Segmentation by Application:
Ringworm Of The Body
Athlete'S Foot
Tinea
Tinea Versicolor
Candida Albicans
Gynecological Anti-Infection Preparation
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer
Apotex Corporation
Fougera (Sandoz)
Medimetriks Pharmaceuticals
Taro Pharmaceuticals
Preferred Pharmaceuticals
Ingenus Pharmaceuticals
Alvogen (CVC Capital Partners and Temasek )
Acella Pharmaceuticals
Dr Marc's Manufacturing
Paddock Laboratories (Perrigo)
Sincerus
Glades Pharmaceuticals (GSK)
Sterimax
Guangzhou Kanghe Pharmaceutical
Tianjin Lisheng Pharmaceutical
Zhejiang Xianju Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

Please note: The report will take approximately 2 business days to prepare and deliver. Show more